Silo Pharma, Inc.
SILO
$0.63
-$0.011-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Cost of Revenue | 0.00% | 7.14% | 0.00% | 0.00% | 0.00% |
| Gross Profit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A Expenses | -10.57% | -10.58% | -17.29% | -37.40% | -6.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.91% | 54.97% | 29.91% | -9.90% | 9.25% |
| Operating Income | -24.40% | -55.83% | -30.61% | 10.06% | -9.46% |
| Income Before Tax | -28.65% | -64.57% | -40.68% | 8.02% | 11.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.65% | -64.57% | -40.68% | 8.02% | 11.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.65% | -54.35% | -40.68% | 8.02% | 11.55% |
| EBIT | -24.40% | -55.83% | -30.61% | 10.06% | -9.46% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 17.74% | -1.37% | -1.65% | 4.98% | 2.54% |
| Normalized Basic EPS | 17.51% | -7.74% | -1.97% | 4.56% | -19.24% |
| EPS Diluted | 17.74% | -1.37% | -1.65% | 4.98% | 2.54% |
| Normalized Diluted EPS | 17.51% | -7.74% | -1.97% | 4.56% | -19.24% |
| Average Basic Shares Outstanding | 56.42% | 45.79% | 38.37% | -3.21% | -9.24% |
| Average Diluted Shares Outstanding | 56.42% | 45.79% | 38.37% | -3.21% | -9.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |